Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
86
datasets available to search
ShareScore release 0.7.1
Dataset results
86 results for “risankizumab”
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
ClinicalTrials.gov study NCT03926169. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03706040. IPD Sharing: YES. Countries: 5. Publications: 1.
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheum
ClinicalTrials.gov study NCT03675308. IPD Sharing: YES. Countries: 39. Publications: 9.
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
ClinicalTrials.gov study NCT03671148. IPD Sharing: YES. Countries: 25. Publications: 9.
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
ClinicalTrials.gov study NCT03104413. IPD Sharing: YES. Countries: 43. Publications: 5.
A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03105128. IPD Sharing: YES. Countries: 44. Publications: 7.
A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03875482. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
ClinicalTrials.gov study NCT03022045. IPD Sharing: YES. Countries: 1. Publications: 1.
High Dose Risankizumab for Psoriasis
ClinicalTrials.gov study NCT05283135. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or Ixekizumab
ClinicalTrials.gov study NCT04102007. IPD Sharing: YES. Countries: 8. Publications: 1.
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis
ClinicalTrials.gov study NCT05969223. IPD Sharing: YES. Countries: 1. Publications: 1.
Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03478787. IPD Sharing: YES. Countries: 9. Publications: 1.
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03398148. IPD Sharing: YES. Countries: 44. Publications: 4.
Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
ClinicalTrials.gov study NCT02443298. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement
ClinicalTrials.gov study NCT04713592. IPD Sharing: YES. Countries: 4. Publications: 0.
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Ca
ClinicalTrials.gov study NCT04908475. IPD Sharing: YES. Countries: 5. Publications: 1.
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT02513459. IPD Sharing: YES. Countries: 9. Publications: 1.
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
ClinicalTrials.gov study NCT03047395. IPD Sharing: YES. Countries: 17. Publications: 4.
Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male Volunteers
ClinicalTrials.gov study NCT02596217. IPD Sharing: Not stated. Countries: 2. Publications: 2.
A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)
ClinicalTrials.gov study NCT02986373. IPD Sharing: YES. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.